Status:
COMPLETED
Reproductive Outcomes of Different Sperm Selection Techniques for ICSI Patients With Abnormal Sperm DNA Fragmentation.
Lead Sponsor:
Ganin Fertility Center
Conditions:
Infertility, Male
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Comparing the reproductive outcomes of different sperm selection techniques; Density gradient centrifugation (DGC), Testicular sperm (Testi), Physiological ICSI (PICSI), and Magnetic activated cell so...
Eligibility Criteria
Inclusion
- Female age was ≤37 years
- Female should has 5≥ metaphase II oocytes
- Males having abnormal SDF levels ≥ 20.3% by TUNEL assay
- Abstinence from 1 to 2 days
- Males having at least 1 million total motile progressive count
Exclusion
- Leukocytospermia
- Presence of varicocele.
- Known genetic abnormality
- Use of sperm donation or cryopreserved sperm
- Use of Oocyte donation
- Use of gestational carrier
- Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previous uterine infection
- Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04482517
Start Date
March 1 2017
End Date
December 1 2018
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ganin Fertility Center
Cairo, Maadi, Egypt, 1728